Beams of Life: Mega in conversation with Professor Stephen Myers OBE

Proton therapy is a new way of beating cancer, with fewer side effects than conventional radiation treatments, explains Stephen Myers, a pioneering nuclear medicine scientist. https://youtu.be/gRULJHjoKRA Professor Stephen Myers OBE – Physicist, proton therapy specialist at ADAM Find the original article here

Advanced Oncotherapy #AVO receives first part of Yantai distribution agreement payment

Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that further to the Company’s announcement of 3 April 2018, the Company has received from Yantai Cipu, through its affiliated entity Liquid Harmony, £6.5 million as the first payment relating to the Distribution Agreement announced on 7 December 2017. The […]

Advanced Oncotherapy #AVO – UK Assembly and Testing Site Agreement

ADVANCED ONCOTHERAPY PLC  UK assembly and testing site agreement Advanced Oncotherapy (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that is has signed a lease with the UK Government’s Science and Technology Facilities Council (“STFC”) to establish a UK testing and assembly site for its next generation proton accelerator, “LIGHT”, at the […]

Dad of two claims pioneering treatment in Prague saved his life – Irish Mirror

By the Irish Mirror The 64-year-old, from Kinsale, Co Cork has ‘never looked back’ An engineer who was diagnosed with prostate cancer claims pioneering treatment abroad saved his life. Eamon Jackson flew 1,000 miles to Prague for proton beam therapy and is now free of the disease. Dad-of-two Eamon monitored his PSA levels – a […]

Advanced Oncotherapy #AVO – GPSL Research on Advanced Oncotherapy Plc

       Free to access research and investor meetings in a post-MiFID2 world Advanced Oncotherapy (AVO-GB): Revamped particle therapy story Recommendation: OUTPERFORM (from NON-RATED) Target Price: 155p (from NIL) Current Price: 46p Click here for full PDF version KEY TAKEAWAY We upgrade AVO to OUTPERFORM with a fair value of 155 GBp. The company […]

Advanced Oncotherapy #AVO – Peter Gyllenhammar AB shareholding

TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: Advanced Oncotherapy plc 1b. Please indicate if the issuer is […]